II. Indications
III. Mechanism
IV. Medications
- Chewable Tablets: 100 mg
- In U.S., Vermox was original trade name and discontinued in 2012
- Rebranded in 2016 as Enverm (at astronomical prices)
V. Dosing: Adults and Children
VI. Adverse Effects
- Transient gastrointestinal symptoms
- Serious (Uncommon to rare)
- Bone Marrow suppression (Agranulocytosis, Neutropenia)
- Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis (SJS/TEN)
VII. Safety
- Unknown safety in first trimester (may be used in later pregnancy)
- Considered safe in Lactation